Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Heart Failure Clinics|March 2, 2023
Use and Prognostic Implications of Cardiac Troponin in COVID-19Laura De Michieli, Allan S Jaffe, Yader SandovalCardiology Clinics|July 19, 2022
Use and Prognostic Implications of Cardiac Troponin in COVID-19Laura De Michieli, Allan S Jaffe, Yader SandovalJACC. Cardiooncology|March 21, 2024
Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis: <i>JACC: CardioOncology</i> State-of-the-Art ReviewLaura De Michieli, Alberto Cipriani, Sabino Iliceto, et al.Journal of Clinical Medicine|October 28, 2023
Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A ReviewAngela Napolitano, Laura De Michieli, Giulio Sinigiani, et al.Journal of the American College of Cardiology|February 11, 2026
Biomarkers for Cardiovascular Drug Development: JACC State-of-the-Art ReviewAlberto Aimo, Javed Butler, Laura De Michieli, et al.Plos One|February 29, 2024
Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: A proof of concept studyMattia Corianò, Corrado Lanera, Laura De Michieli, et al.Atherosclerosis|September 3, 2019
Long-term prognostic value of coronary flow reserve in psoriasis patientsStefano Piaserico, Elena Osto, Giulia Famoso, et al.International Journal of Molecular Sciences|February 25, 2023
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionBeatrice Moccaldi, Laura De Michieli, Marco Binda, et al.The American Journal of Medicine|July 13, 2022
Structural Cardiac Abnormalities in Patients with Atrial Fibrillation/Flutter and Myocardial InjuryLaura De Michieli, Ronstan Lobo, Luciano Babuin, et al.JACC. Advances|March 21, 2026
Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial InfarctionJonathan D Knott, Laura De Michieli, Olatunde Ola, et al.Pageof 6